(Q37278998)

19 August 2017

1 reference

title

Detection of tumours of the urinary tract in voided urine (English)

1 reference

19 August 2017

Ellen C Zwarthoff

1

1 reference

19 August 2017

1 September 2008

1 reference

Scandinavian Journal of Urology and Nephrology. Supplement

19 August 2017

1 reference

19 August 2017

147-153

1 reference

19 August 2017

218

1 reference

Global cancer statistics, 2002

19 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

The clinical epidemiology of superficial bladder cancer. Dutch South-East Cooperative Urological Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Patients' perceived burden of cystoscopic and urinary surveillance of bladder cancer: a randomized comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Urinary tract infection and patient satisfaction after flexible cystoscopy and urodynamic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Surveillance for bladder cancer: the management of 4.8 million people. South-west Urologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Urine markers for bladder cancer surveillance: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Usefulness of urinary NMP22 to detect tumor recurrence of superficial bladder cancer after transurethral resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

The role of deoxyribonucleic acid methylation in development, diagnosis, and prognosis of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Tumor suppressor loci in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Surveillance with microsatellite analysis of urine in bladder cancer patients treated by radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Protein profiling in urine for the diagnosis of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

ProteinChip technology reveals distinctive protein expression profiles in the urine of bladder cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Urinary biomarker profiling in transitional cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Uronate peaks and urinary hyaluronic acid levels correlate with interstitial cystitis severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Adherence to Surveillance Among Patients With Superficial Bladder Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

Patient opinion of urinary tests versus flexible urethrocystoscopy in follow-up examination for superficial bladder cancer: a utility analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802283953

10.1080/03008880802283953

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18815929